Literature DB >> 11110038

Concentration of vascular endothelial growth factor in the subretinal fluid of retinal detachment.

C Y Su1, M T Chen, W S Wu, W C Wu.   

Abstract

The purpose of this study was to investigate the release of vascular endothelial growth factor (VEGF) within the subretinal fluid in eyes with retinal detachment. Subretinal fluid was collected from patients with retinal detachment undergoing surgery for scleral buckling. Serum samples were also collected. The concentration of VEGF in the subretinal fluid and serum was investigated by enzyme-linked immunospecific assay. The average concentration of VEGF in serum samples was 168 +/- 153 pg/ml (mean +/- standard deviation). It was lower than the VEGF concentration in the subretinal fluid (485 +/- 570 pg/ml) in the same 18 patients with retinal detachment (p < 0.05). The average concentration of VEGF was 355 +/- 373 pg/ml in 31 samples of the subretinal fluid collected from simple rhegmatogenous retinal detachment. It was lower than the average concentration of 901 +/- 385 pg/ml in 8 samples of the subretinal fluid from retinal detachment with proliferative vitreoretinopathy (p < 0.05). The results suggest that the relative retinal ischemia in detached retina increases the release of VEGF into the subretinal space. Also, the concentration of VEGF within the subretinal fluid in proliferative vitreoretinopathy was higher than in simple rhegmatogenous retinal detachment.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11110038     DOI: 10.1089/jop.2000.16.463

Source DB:  PubMed          Journal:  J Ocul Pharmacol Ther        ISSN: 1080-7683            Impact factor:   2.671


  7 in total

Review 1.  Involvement of Müller glial cells in epiretinal membrane formation.

Authors:  Andreas Bringmann; Peter Wiedemann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-05-05       Impact factor: 3.117

2.  Intrasilicone oil injection of bevacizumab at the end of retinal reattachment surgery for severe proliferative vitreoretinopathy.

Authors:  K Ghasemi Falavarjani; M Hashemi; M Modarres; A Hadavand Khani
Journal:  Eye (Lond)       Date:  2014-02-21       Impact factor: 3.775

3.  Vascular endothelial growth factor modulates the function of the retinal pigment epithelium in vivo.

Authors:  Mohammad Dahrouj; Oday Alsarraf; Jake C McMillin; Yueying Liu; Craig E Crosson; Zsolt Ablonczy
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-09       Impact factor: 4.799

4.  Minimal effects of VEGF and anti-VEGF drugs on the permeability or selectivity of RPE tight junctions.

Authors:  Shaomin Peng; Ron A Adelman; Lawrence J Rizzolo
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-12-30       Impact factor: 4.799

5.  Interleukin and growth factor levels in subretinal fluid in rhegmatogenous retinal detachment: a case-control study.

Authors:  Lukas J A G Ricker; Aize Kijlstra; Alfons G H Kessels; Wilco de Jager; Albert T A Liem; Fred Hendrikse; Ellen C La Heij
Journal:  PLoS One       Date:  2011-04-27       Impact factor: 3.240

6.  Comparison between Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor Levels in Rhegmatogenous Retinal Detachment.

Authors:  Andi Muhammad Ichsan; Dyah Ayu Windy; Habibah Setyawati Muhiddin; Muhammad Nasrum Massi; Itzar Chaidir Islam
Journal:  J Ophthalmol       Date:  2021-12-06       Impact factor: 1.909

7.  Vitrectomy and external drainage of subretinal fluid containing high concentration of vascular endothelial growth factor for advanced coats disease.

Authors:  Fukutaro Mano; Itsuka Matsushita; Hiroyuki Kondo; Shoko Utamura; Chiori Kondo; Shunji Kusaka
Journal:  Sci Rep       Date:  2021-09-29       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.